首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Exploration of targeted antitumor therapy

缩写:

ISSN:2692-3114

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引375
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Dilpreet Singh,Akshay Kumar Dilpreet Singh
The evolution of nanocarrier-based drug delivery systems has transformed the paradigm of cancer therapeutics, advancing from conventional cytotoxic formulations to intelligent, adaptive nanosystems capable of precision targeting. Early-gene...
Emily Kay,Mahnaz Kazi,Jeremy Burton et al. Emily Kay et al.
Immune checkpoint inhibitor (ICI) therapy has revolutionized metastatic melanoma treatment, yet only a subset of patients respond effectively, and the treatment can induce a variety of immune-related adverse events (irAEs), including coliti...
Yilin Ma,Mengqin Guo,Yang Liu et al. Yilin Ma et al.
Fibroblast growth factor receptor 1 (FGFR1) is crucial in the progression of various cancers, participating in the processes of cell proliferation, survival, and differentiation. FGFR1 plays a role in the resistance to immune checkpoint inh...
Lauren A Dalvin,Kjersten J Anderson,Tommy A Rinkoski et al. Lauren A Dalvin et al.
Radiation exposure to the eye during cancer treatment can lead to ocular radiation injury (ORI), a devastating condition that can have a profound and permanent impact on vision-related quality of life. Rodent models do not have adequate ocu...
Tallha W Khawaja,Lei Zhao,Raiq Siddiq et al. Tallha W Khawaja et al.
Colorectal cancer (CRC) is a significant global health problem, ranking as the third most common cancer and the second leading cause of cancer deaths in the world. The highest incidence of CRC is found in developed regions, thus underlining...
Panagiotis J Vlachostergios Panagiotis J Vlachostergios
Therapeutic cancer vaccines harness the adaptive immune system to eradicate malignancies by targeting tumor-specific antigens. This review charts the evolution of cancer vaccine platforms-from shared tumor-associated antigens (TAAs) and den...
Ger T Rijkers,Yonah Langcauon,Pippe van Leersum et al. Ger T Rijkers et al.
The realization that the composition and functionality of gut microbiota have an impact on the outcome of immune checkpoint inhibition (ICI) therapy of cancer has initiated research into the potential of microbiota management as adjunctive ...
Dilpreet Singh,Satvir Singh,Nitin Tandon et al. Dilpreet Singh et al.
The convergence of DNA nanotechnology with nanofluidics has catalyzed a transformative shift in precision drug delivery. DNA origami, a self-assembled nanoscale architecture constructed via programmable base pairing, offers atomically preci...
Prashant H Gohil,Gopal Avashthi Prashant H Gohil
Cancer is one of the leading global causes of mortality and morbidity, so it needs early diagnosis and therapies. Traditional diagnostic and therapeutic strategies are inadequate due to several limitations, such as poor specificity, systemi...
Abdul Wali Khan,Simran Chandra,Himil Mahadevia et al. Abdul Wali Khan et al.
Immune checkpoint inhibitors (ICIs) are established treatments for various malignancies, including lung, kidney, and colorectal cancers. However, their broad use has led to an increase in immune-related adverse events (irAEs), with thyroidi...